By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Miscellaneous antihyperlipidemic agents > Endur-acin > Niacin Dosage
Miscellaneous antihyperlipidemic agents
https://themeditary.com/dosage-information/niacin-dosage-2469.html

Niacin Dosage

Drug Detail:Endur-acin (Niacin (nicotinic acid) [ nye-a-sin ])

Drug Class: Miscellaneous antihyperlipidemic agents

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Hyperlipoproteinemia Type IV (Elevated VLDL)

Immediate-release:

  • Initial dose: 250 mg orally once a day following the evening meal; increase frequency and/or dose every 4 to 7 days to the desired effect or first-level therapeutic dose (1.5 to 2 g/day in 2 to 3 divided doses); if the response is inadequate after 2 months, the dose can be increased at 2 to 4 week intervals to 1
  • Maintenance dose: 1 to 2 g orally 2 to 3 times a day
  • Maximum dose: 6 g/day (in 2 to 3 divided doses)

Sustained-release:
  • Weeks 1 to 4: 500 mg orally at bedtime
  • Weeks 5 to 8: 1000 mg orally at bedtime
  • After week 8: Titrate to patient response and tolerance; if response to 1000 mg a day is inadequate, increase to 1500 mg a day; may subsequently increase to 2000 mg a day: daily dose should not be increased more than 500 mg in a 4-week period
  • Maintenance dose: 1000 to 2000 mg orally at bedtime
  • Maximum dose: 2000 mg/day

Comments:
  • Individualize doses according to patient response.
  • Women may respond at lower doses than men.
  • Tolerance to flushing develops rapidly over the course of several weeks; flushing, pruritus, and GI distress can be reduced by slowly increasing the dose and avoiding administration on an empty stomach.
  • Concomitant alcoholic drinks, hot drinks, or spicy foods may increase the side effects of flushing and pruritus and should be avoided near the time this drug is taken.
  • If therapy with the extended-release formulation is discontinued for an extended period, reinstitution of therapy should include a titration phase.
  • The extended-release formulation should be taken whole and should not be broken, crushed, or chewed before swallowing.
  • Flushing can be minimized by pretreatment with aspirin or nonsteroidal anti-inflammatory drugs.
  • Flushing, pruritus, and GI distress can be reduced by slowly increasing the dose and avoiding administration on an empty stomach.

Uses:
  • To reduce elevated TC, LDL-C, Apo B and TG, and to increase HDL-C in patients with primary hyperlipidemia and mixed dyslipidemia; to reduce the risk of recurrent nonfatal myocardial infarction in patients with a history of myocardial infarction and hyperlipidemia
  • In combination with a bile acid binding resin: Slows progression or promotes regression of atherosclerotic disease in patients with a history of coronary artery disease (CAD) and hyperlipidemia
  • As an adjunct to diet to reduce elevated TC and LDL-C in adult patients with primary hyperlipidemia
  • To reduce TG in adult patients with severe hypertriglyceridemia

Usual Adult Dose for Hyperlipoproteinemia Type V (Elevated Chylomicrons + VLDL)

Immediate-release:

  • Initial dose: 250 mg orally once a day following the evening meal; increase frequency and/or dose every 4 to 7 days to the desired effect or first-level therapeutic dose (1.5 to 2 g/day in 2 to 3 divided doses); if the response is inadequate after 2 months, the dose can be increased at 2 to 4 week intervals to 1
  • Maintenance dose: 1 to 2 g orally 2 to 3 times a day
  • Maximum dose: 6 g/day (in 2 to 3 divided doses)

Sustained-release:
  • Weeks 1 to 4: 500 mg orally at bedtime
  • Weeks 5 to 8: 1000 mg orally at bedtime
  • After week 8: Titrate to patient response and tolerance; if response to 1000 mg a day is inadequate, increase to 1500 mg a day; may subsequently increase to 2000 mg a day: daily dose should not be increased more than 500 mg in a 4-week period
  • Maintenance dose: 1000 to 2000 mg orally at bedtime
  • Maximum dose: 2000 mg/day

Comments:
  • Individualize doses according to patient response.
  • Women may respond at lower doses than men.
  • Tolerance to flushing develops rapidly over the course of several weeks; flushing, pruritus, and GI distress can be reduced by slowly increasing the dose and avoiding administration on an empty stomach.
  • Concomitant alcoholic drinks, hot drinks, or spicy foods may increase the side effects of flushing and pruritus and should be avoided near the time this drug is taken.
  • If therapy with the extended-release formulation is discontinued for an extended period, reinstitution of therapy should include a titration phase.
  • The extended-release formulation should be taken whole and should not be broken, crushed, or chewed before swallowing.
  • Flushing can be minimized by pretreatment with aspirin or nonsteroidal anti-inflammatory drugs.
  • Flushing, pruritus, and GI distress can be reduced by slowly increasing the dose and avoiding administration on an empty stomach.

Uses:
  • To reduce elevated TC, LDL-C, Apo B and TG, and to increase HDL-C in patients with primary hyperlipidemia and mixed dyslipidemia; to reduce the risk of recurrent nonfatal myocardial infarction in patients with a history of myocardial infarction and hyperlipidemia
  • In combination with a bile acid binding resin: Slows progression or promotes regression of atherosclerotic disease in patients with a history of coronary artery disease (CAD) and hyperlipidemia
  • As an adjunct to diet to reduce elevated TC and LDL-C in adult patients with primary hyperlipidemia
  • To reduce TG in adult patients with severe hypertriglyceridemia

Usual Adult Dose for Vitamin/Mineral Supplementation

Recommended Dietary Allowance (RDA):

  • Males: 16 mg/day
  • Females: 14 mg/day
  • Pregnancy: 18 mg/day
  • Lactation: 17 mg/day

Comments:
  • Niacin may be given orally and also parenterally as a component of injectable multivitamin additives contained in parenteral nutrition products.
  • The best way to get the daily requirement of essential vitamins is to eat a balanced diet that contains a variety of foods.

Uses:
  • Recommended Dietary Allowance (RDA): Average daily level of intake that is enough to meet the nutrient requirements of nearly all (97 to 98%) healthy people.

Usual Adult Dose for Vitamin/Mineral Supplementation during Pregnancy/Lactation

Recommended Dietary Allowance (RDA):

  • Males: 16 mg/day
  • Females: 14 mg/day
  • Pregnancy: 18 mg/day
  • Lactation: 17 mg/day

Comments:
  • Niacin may be given orally and also parenterally as a component of injectable multivitamin additives contained in parenteral nutrition products.
  • The best way to get the daily requirement of essential vitamins is to eat a balanced diet that contains a variety of foods.

Uses:
  • Recommended Dietary Allowance (RDA): Average daily level of intake that is enough to meet the nutrient requirements of nearly all (97 to 98%) healthy people.

Usual Pediatric Dose for Vitamin/Mineral Supplementation

Adequate Intake (AI):

  • Infants 0 to 6 months: 2 mg/day
  • Infants 7 to 12 months: 4 mg/day

Recommended Dietary Allowance (RDA):
  • Children 1 to 3 years: 6 mg/day
  • Children 4 to 8 years: 8 mg/day
  • Children 9 to 13 years: 12 mg/day
  • Males: 14 to 18 years: 16 mg/day
  • Females: 14 to 18 years: 14 mg/day
  • Pregnancy: 18 mg/day
  • Lactation: 17 mg/day

Comments:
  • Niacin may be given orally and also parenterally as a component of injectable multivitamin additives contained in parenteral nutrition products.
  • The best way to get the daily requirement of essential vitamins is to eat a balanced diet that contains a variety of foods.

Uses:
  • Adequate Intake (AI): When there is not enough evidence to develop an RDA, the AI is set at a level that is thought to ensure enough nutrition.
  • Recommended Dietary Allowance (RDA): Average daily level of intake that is enough to meet the nutrient requirements of nearly all (97 to 98%) healthy people.

Usual Pediatric Dose for Vitamin/Mineral Supplementation during Pregnancy/Lactation

Adequate Intake (AI):

  • Infants 0 to 6 months: 2 mg/day
  • Infants 7 to 12 months: 4 mg/day

Recommended Dietary Allowance (RDA):
  • Children 1 to 3 years: 6 mg/day
  • Children 4 to 8 years: 8 mg/day
  • Children 9 to 13 years: 12 mg/day
  • Males: 14 to 18 years: 16 mg/day
  • Females: 14 to 18 years: 14 mg/day
  • Pregnancy: 18 mg/day
  • Lactation: 17 mg/day

Comments:
  • Niacin may be given orally and also parenterally as a component of injectable multivitamin additives contained in parenteral nutrition products.
  • The best way to get the daily requirement of essential vitamins is to eat a balanced diet that contains a variety of foods.

Uses:
  • Adequate Intake (AI): When there is not enough evidence to develop an RDA, the AI is set at a level that is thought to ensure enough nutrition.
  • Recommended Dietary Allowance (RDA): Average daily level of intake that is enough to meet the nutrient requirements of nearly all (97 to 98%) healthy people.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

  • Mild to moderate liver dysfunction with alcohol use: No specific dose adjustment guidelines have been suggested; however, caution is recommended.
  • Severe or unexplained hepatic dysfunction: Contraindicated

Precautions

Safety and efficacy of the extended-release formulation have not been established in patients younger than 16 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • Switching from immediate release to extended release products: Patients previously receiving other niacin products should be started with the recommended niacin extended-release tablets titration schedule, and the dose should subsequently be individualized based on patient response.
  • This drug should be administered at bedtime following a snack.
  • Concomitant alcohol or hot drinks may increase flushing and pruritus and should be avoided at the time of dosing.

General:
  • Equivalent doses of niacin extended-release tablets should not be substituted for sustained-release (modified-release, timed-release) niacin preparations or immediate-release (crystalline) niacin.
  • Extended-release formulations should not be broken, crushed, or chewed before swallowing.

Frequently asked questions

  • How long does niacin stay in the human system?
Share this Article
Latest News
Medical News

Gastrointestinal cancer: Can eating chicken shorten lifespan?

May 12, 2025
Shingles vaccine may lower heart disease risk by up to 8 years
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by